Bone/Mineral Metabolism News

Adults with epilepsy who initiated any osteoporosis drug therapy had a lower 3-year mortality risk compared with those who did not take a medication, according to study data published in Bone.

A subcutaneous injection of leuprolide acetate every 6 months was effective and well tolerated in treating central precocious puberty in children, according to trial data.

In this video exclusive, Putting It Into Practice columnist Jonathan D. Leffert, MD, talks with Natalie Cusano, MD, about hyperparathyroidism and osteoporosis.

Evaluating bone mineral density can help predict atherosclerotic CVD events in women, according to a study published in Heart.

Postmenopausal women who sustain any type of initial fracture are at a higher risk for a subsequent fracture, according to a study published in EClinicalMedicine.

Patients with both X-linked hypophosphatemia and tumor-induced osteomalacia can benefit from phosphorus replacement therapy, according to two presentations at the United Rheumatology Spring Virtual conference.

Transgender adolescents treated with gender-affirming hormone therapy early in puberty experience bone development more similar to that of their experienced gender compared with their gender assigned at birth, according to study data.

A report from the National Osteoporosis Foundation details fracture rates for all 50 U.S. states and highlights ethnic and racial disparities among Medicare beneficiaries for hospitalization, mortality and health costs.

The U.S. Preventive Services Task Force said there is not enough evidence to assess the balance of benefits and harms of vitamin D deficiency screening in nonpregnant, asymptomatic adults.

Older men with higher bone mineral density and preserved cortical bone are less likely to experience a major adverse coronary event, according to a study published in the Journal of Bone and Mineral Research.